Product logins

Find logins to all Clarivate products below.

home   •  Research Reports  •  DRG Market Assessment Reports

Diabetic Retinopathy/Diabetic Macular Edema | TreatmentTrends | US | 2014

Login to access report north_east
Contact sales account_box

This report provides detailed analysis of the current and projected mar-kets for diabetic retinopathy (DR) and diabetic macular edema (DME). The DR population represents more than 5.8 million diagnosed patients in the U.S. with 2.3 million DR patients also suffering from DME.
TreatmentTrends: Diabetic Retinopathy/Diabetic Macular Edema (U.S.) is an annual syndicated report series that offers a snapshot of DR and DME market dynamics and competitive landscape through comprehensive primary research with retinal specialists and general ophthalmologists. The report covers the current use of intravitreal injec-tions, in particular anti-VEGF agents, for the treatment of DME, as well as attitudes and perceptions toward these products, advantages and disadvantages, ideal patient types, barriers to growth, promotional activ-ity, and anticipated use. In addition, respondents are queried about their awareness of and interest in products in development.

Contact sales account_box
Login to access report north_east

Related Market Assessment Reports

Report
Atopic Dermatitis / Atopic Eczema – Current Treatment – Current Treatment: Physician Insights – Atopic Dermatitis / Atopic Eczema – Moderate to Severe (US)
AD is a chronic inflammatory skin condition characterized by recurrent flares and persistent itch, significantly impacting patient quality of life. Moderate to severe AD continues to undergo rapid…
north_east
Report
Renal Anemia – Current Treatment – Treatment Algorithms: Claims Data Analysis – Renal Anemia (US)
Renal anemia is a common complication of chronic kidney disease (CKD) resulting from insufficient erythropoietin production by impaired kidneys. The primary goal of renal anemia treatment is to…
north_east
Report
Myasthenia Gravis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Myasthenia Gravis (US)
Myasthenia gravis (MG) is a rare neuromuscular disorder caused by autoantibodies at the neuromuscular junction. It leads to fluctuating muscle weakness and fatigue. Standard treatments include…
north_east
Report
Squamous Cell Carcinoma of the Head and Neck – Landscape & Forecast – Disease Landscape & Forecast (G7)
Squamous cell carcinoma of the head and neck (SCCHN) is the seventh most commonly diagnosed cancer. It encompasses a spectrum of heterogeneous tumors originating at multiple sites in the head and…
north_east
Report
Hemophilia A – Current Treatment – Current Treatment: Physician Insights – Hemophilia A with Inhibitors (US)
Development of neutralizing antibodies against factor VIII replacement is the most significant clinical complication in hemophilia A, necessitating specialized and often high-cost management…
north_east

Follow us

Contact us

Sales enquiries north_east
Customer service north_east
Support north_east